openPR Logo
Press release

Scope in OTC Cough, Cold & Allergy Medicines Market: Size | Trends | Key Players |and Forecast till 2022

03-14-2018 03:52 PM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

A fresh study, covering “OTC Cough, Cold & Allergy Medicine Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make the research a powerful source for analysts and industry experts who are looking to gain necessary knowledge about the prevailing market trends, opportunities and drivers present in the OTC Cough, Cold & Allergy Medicine market.

Request for Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=71

Factors as such are playing a crucial role in further boosting the demand for OTC cough, cold and allergy medicines. In addition, growing number of immunosuppressed patients and expanding global geriatric population is anticipated to drive the growth of the market. Fact.MR’s recently published report reveals that the global cough, cold and allergy medicine market is set to witness 4.9% between 2017 and 2022. This market is estimated to stand at around US$ 37,323 Mn towards the end of the forecast period.

Following insights from Fact.MR’s global OTC cough, cold and allergy market will be important for market’s future growth

1- The OTC cough, cold and allergy medicines market in Asia Pacific excluding Japan (APEJ) is anticipated to remain highly attractive throughout the assessment period. In 2017 and beyond, the region is projected to command for a noteworthy revenue share of the global market. This is primarily owing to dropping air quality and increase pollution that is resulting in higher occurrence of respiratory ailments. In addition, rapid adoption of OTC medicines owing to their convenience of purchase and cost-efficiency is facilitating the growth of the market in the region.

2- On the basis of drug type, antihistamine is anticipated to command for over one-third revenues share of the market by the end of 2017. Antihistamines drugs help in restricting the histamine release from histamine-1 receptors, moreover these drugs can effectively treat watery eyes or runny nose, inflammation (redness), sneezing and swelling (edema).

3- By OCT channel, pharmacies will continue to be the top OCT channel for sales of allergy, cold and cough drugs between 2017 and 2022. During the same time, the drug store segment is projected to retain its second spot.

4- Based on dosage, the tablet segment is projected to command for a significant share of the market in terms of revenue and is likely to reach a valuation of nearly US$ 12,425 Mn over 2022.

Competition Tracking

Fact.MR has profiled some of the key players in its report, which include Allergen, Bristol-Myers Squib Co., Prestige Brands Holdings, Inc., Pfizer Inc., GlaxoSmithKline Plc., Reckitt Benckiser Group Plc., AstraZaneca Plc., Johnson & Johnson Service, Inc., Procter & Gamble Co., Sanofi-Aventis, Novartis AG, Merck & Co., and Sun Pharmaceutical Industries Ltd. Many of these companies are concentrating on improving the product efficiency in order to increase their market presence.

Browse Full Report with TOC – https://www.factmr.com/report/71/otc-cough-cold-allergy-medicine-market

Table of Contents:

Global OTC Cough, Cold and Allergy Medicines Market – Executive Summary
Global OTC Cough, Cold and Allergy Medicines Market Overview
2.1. Introduction
2.1.1. Global OTC Cough, Cold and Allergy Medicines Market Taxonomy
2.1.2. Global OTC Cough, Cold and Allergy Medicines Market Definition
2.2. Global OTC Cough, Cold and Allergy Medicines Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global OTC Cough, Cold and Allergy Medicines Market Y-o-Y Growth
2.3. Global OTC Cough, Cold and Allergy Medicines Market Dynamics
2.3.1. Drivers
2.3.2. Restraints
2.3.3. Trends
2.4. Supply Chain
2.5. Epidemiology
2.6. List of Distributors
2.7. Average Pricing Analysis
2.8. Regulations
2.9. Key Participants Market Presence (Intensity Map) By Region
Global OTC Cough, Cold and Allergy Medicines Market Analysis and Forecast By Drug Type
3.1. Global OTC Cough, Cold and Allergy Medicines Market Size and Forecast By Drug Type, 2012-2022
3.1.1. Antihistamine OTC Cough, Cold and Allergy Medicines Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. Expectorants OTC Cough, Cold and Allergy Medicines Market Size and Forecast, 2012-2022
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region
3.1.3. Bronchodialators OTC Cough, Cold and Allergy Medicines Market Size and Forecast, 2012-2022
3.1.3.1. Revenue (US$ Mn) Comparison, By Region
3.1.3.2. Market Share Comparison, By Region
3.1.3.3. Y-o-Y growth Comparison, By Region
Continued…….

Check Discount on this Report – https://www.factmr.com/connectus/sample?flag=D&rep_id=71

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Scope in OTC Cough, Cold & Allergy Medicines Market: Size | Trends | Key Players |and Forecast till 2022 here

News-ID: 978800 • Views:

More Releases from Fact.MR

USA Solar Light Towers Industry Outlook 2025-2035: Innovation, Growth, and Demand Trends
USA Solar Light Towers Industry Outlook 2025-2035: Innovation, Growth, and Deman …
The U.S. market for solar light towers-portable, off-grid, solar-powered lighting systems-is entering a phase of strong, sustained growth. Industries such as construction, infrastructure development, event management, emergency response, mining, and remote industrial operations are increasingly shifting toward solar-based lighting solutions due to their lower operating costs, zero emissions, quiet operation, and minimal maintenance requirements. With growing emphasis on sustainability and operational efficiency, solar light towers are steadily replacing traditional diesel-powered units
UK Cancer and Tumor Biomarker-based Assay Industry Outlook 2025-2035: Key Developments and Future Scope
12-12-2025 | Health & Medicine
Fact.MR
UK Cancer and Tumor Biomarker-based Assay Industry Outlook 2025-2035: Key Develo …
Cancer and tumor biomarker-based assays are analytical tests that detect biological markers associated with cancer presence, progression, recurrence risk, prognosis, and treatment response. These assays play a crucial role in early diagnosis, precision medicine, therapy selection, monitoring minimal residual disease, and assessing recurrence, making them indispensable in modern oncology care. In the United Kingdom, demand for biomarker-based assays is growing strongly due to rising cancer incidence, expanding adoption of personalized medicine,
UK Bleaching Clay Industry Forecast 2025-2035: Trends and Growth Insights
UK Bleaching Clay Industry Forecast 2025-2035: Trends and Growth Insights
Bleaching clay - also called decolorizing clay or activated clay - is a specialty mineral used primarily in the refining and purification of edible oils, fats, waxes, and various industrial liquids. It is valued for its high surface area and adsorption properties, which allow it to remove color bodies, impurities, trace metals, oxidation products, and other undesired components. In the United Kingdom, demand for bleaching clay is closely linked to
UK Veterinary Dietary Supplements Industry Outlook 2025-2035: Key Developments and Future Scope
12-12-2025 | Food & Beverage
Fact.MR
UK Veterinary Dietary Supplements Industry Outlook 2025-2035: Key Developments a …
The UK market for veterinary dietary supplements is experiencing strong growth as pet owners become increasingly health-conscious and veterinarians emphasize preventive wellness. Rising adoption of premium pet foods, growing awareness about joint health, immunity, digestive support, and the overall humanization of pets continue to fuel demand. Supplements formulated for dogs, cats, and production animals are becoming mainstream, supported by innovations in clean-label ingredients and species-specific nutrition. Quick Stats (2025-2035) 2025 Market Value:

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to